Statins as gut microbiome modulators for ulcerative colitis: a failed promise?
NCT ID NCT04883840
First seen Nov 25, 2025 · Last updated May 01, 2026 · Updated 21 times
Summary
This study tested whether statins, a common cholesterol drug, could change gut bacteria to reduce inflammation in people with ulcerative colitis. It included 177 adults with mild to moderate disease. The study was terminated early, so results are limited, but the idea was to see if statins could shift gut bacteria toward a healthier profile and improve disease activity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AZ Delta
Roeselare, West-Vlaanderen, 8800, Belgium
-
Imelda Ziekenhuis
Bonheiden, Antwerp, 2820, Belgium
-
UZ Leuven
Leuven, Vlaams-Brabant, 3000, Belgium
Conditions
Explore the condition pages connected to this study.